InvestorsHub Logo
Followers 355
Posts 9910
Boards Moderated 2
Alias Born 06/23/2007

Re: None

Wednesday, 07/22/2020 11:42:23 AM

Wednesday, July 22, 2020 11:42:23 AM

Post# of 4
So the target is Reviva Pharmaceuticals


Tenzing Acquisition Corp SPAC merging with Reiva Pharmaceuticals


https://finance.yahoo.com/news/tenzing-acquisition-corp-reviva-pharmaceuticals-115400189.html


Looks like a solid pipeline of phase 2 and 3 psych drugs.

http://revivapharma.com/product_pipeline/


How to value it though? Post merger enterprise valuation $119m uses $10 price for the calculation. According to last Q SEC filings, there are only 2.7m shares outstanding.

Nobody here yet- but would appreciate any thoughts on the valuation here, or (better yet) some comps.

Cheers!